Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 18;169(11):225.
doi: 10.1007/s00705-024-06156-7.

Generation of canine neutralizing antibodies against canine parvovirus by single B cell antibody technology

Affiliations

Generation of canine neutralizing antibodies against canine parvovirus by single B cell antibody technology

Zhihao Wang et al. Arch Virol. .

Abstract

Canine parvovirus (CPV) is a significant threat to canines and is widely distributed worldwide. While vaccination is currently the most effective preventive measure, existing vaccines are not able to offer comprehensive and dependable protection against CPV infection. Hence, there is a need to explore alternative or complementary strategies to tackle this problem. In this study, we present an approach for the efficient screening of canine antibodies targeting CPV using a single B cell antibody technique. We sorted single IgM- IgG+ CPV+ B cells from canine peripheral blood mononuclear cells using fluorescence-activated cell sorting (FACS) and obtained the variable region genes of heavy and light chains (VH and VL) by nested PCR amplification. Canine monoclonal antibodies were expressed in HEK293 cells, and a total of 60 antibodies were obtained, five of which demonstrated neutralizing activity against CPV. Those findings demonstrate the effectiveness of the method for obtaining canine monoclonal antibodies, which in turn aids in the identification and screening of neutralizing antibodies against various canine pathogens.

PubMed Disclaimer

References

    1. Parrish CR, Aquadro CF, Strassheim ML, Evermann JF, Sgro JY, Mohammed HO (1991) Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol 65:6544–6552 - DOI - PubMed - PMC
    1. Decaro N, Buonavoglia C (2012) Canine parvovirus–a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 155:1–12 - DOI - PubMed
    1. Pollock RV, Carmichael LE (1982) Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 180:37–42 - PubMed
    1. Levine MM (2019) Monoclonal Antibody Therapy for Ebola Virus Disease. N Engl J Med 381:2365–2366 - DOI - PubMed
    1. Shigle TL, Bashir Q (2020) Advancement in monoclonal antibody therapy for multiple myeloma. Lancet Haematol 7:e354–354e355 - DOI - PubMed

LinkOut - more resources